This is one of the most exciting parts of our economy. This is somewhere we can lead the world.
how much privacy are we going to give up in the name of security?
Today, we are here to explore the various issues surrounding the growth and prevalence of Physician-Owned Distributors, ...
the fraud and abuse risks, as well as (and more importantly) the patient safety concerns related to PODs, are equally ap...
Senator Hatch and I will be referring information about this allegation and about possible Sunshine Act violations to th...
The average cost, according to what I've been told, for a pharmaceutical drug is about a billion dollars...
Transparency might not prevent every unnecessary surgery, but it's a good place to start.
We look forward to working with the Senate Finance Committee and the Subcommittee on Health in the coming months to help...
Do you believe, as prior commissioners have--every one has told me this--that the Dietary Supplement Health and Educatio...
If we reduce that data exclusivity time, especially with regard to bio, you're talking about having to charge a lot more...
If we don't allow enough data exclusivity time, we're not going to develop these therapies, especially in bio, because b...
One issue that significantly affects many entities in my home State is the FDA's October 2014 proposed guidance on the r...
I'm very concerned about data exclusivity.
Ranking Member Wyden and I will be making a formal referral to the HHS Office of Inspector General and the Department of...
inherently suspect
the proliferation of PODs and the lack of guidance as to how these arrangements square with existing Federal law.
I hope that today's hearing will be another important step in our ongoing efforts to provide appropriate oversight and e...
There is really an urgent need for more transparency.
